Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. (688108)

Market Closed
11 Aug, 06:57
SSE SSE
¥
18. 12
-0.54
-2.8939%
¥
4.38B Market Cap
- P/E Ratio
0.4% Div Yield
19.76M Volume
- Eps
¥ 18.66
Previous Close
Add Transaction
Day Range
18.1 19.06
Year Range
14.59 47
Want to track 688108 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688108 closed today lower at ¥18.12, a decrease of -2.8939% from yesterday's close, completing a monthly decrease of -1.7354% or -¥0.32. Over the past 12 months, 688108 stock lost -8.2532%.
688108 is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688108 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Sino Medical Sciences Technology Inc. (688108) FAQ

What is the stock price today?

The current price is ¥18.12.

On which exchange is it traded?

Sino Medical Sciences Technology Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688108.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 4.38B.

Has Sino Medical Sciences Technology Inc. ever had a stock split?

No, there has never been a stock split.

Sino Medical Sciences Technology Inc. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Jianhua Sun CEO
SSE Exchange
CNE100003NY2 ISIN
CN Country
652 Employees
10 Jul 2020 Last Dividend
- Last Split
- IPO Date

Overview

Sino Medical Sciences Technology Inc. is a prominent medical device company focused on the research, development, production, and distribution of interventional devices within China. Since its inception in 2007, the company has been dedicated to advancing the intervention technologies available in the healthcare market. It has established a strong presence in the industry, thanks to its commitment to innovation, quality, and patient safety. Headquartered in Tianjin, China, Sino Medical continues to be at the forefront of developing sophisticated medical devices that cater to the evolving needs of patients and healthcare providers alike.

Products and Services

  • Coronary Drug Stents: Sino Medical Sciences Technology Inc. offers advanced coronary drug stents designed to treat patients with coronary artery disease. These stents gradually release medication that helps prevent the artery from narrowing again after the stent has been placed, thus improving blood flow and reducing the likelihood of future heart-related complications.
  • Coronary Balloons: The company's coronary balloons are used in angioplasty procedures to open up blocked or narrowed coronary arteries, restoring blood flow to the heart. These balloons, when inflated, compress the plaque against the artery walls, helping to alleviate symptoms of heart disease, such as chest pain and shortness of breath.
  • Intracranial Rapid Exchange Balloons: Specifically designed for neurological applications, these balloons facilitate treatments within the brain's vascular system. They are used in specialized procedures to navigate through the intricate and delicate vessels of the brain, offering a minimally invasive option for treating cerebral vascular conditions.
  • Intracranial Drug-Eluting Stents: These are specialized stents used to address cerebrovascular diseases. Similar to coronary drug stents, these devices are deployed within the brain's arteries, releasing medication over time to prevent the treated artery from narrowing, thus reducing the risk of stroke and other complications associated with intracranial atherosclerosis.

Contact Information

Address: TEDA Biomedical R&D Building, Tianjin, China, 300457
Phone: 86 22 5986 2900